We welcome the decision by the EMA to routinely offer parallel scientific advice with HTA bodies and other relevant stakeholders as part of its scientific advice activities.
EuropaBio and the Deerfield Institute have partnered to carry out a survey on the current state of regulatory and health technology assessment (HTA) advice with a special focus on small and medium sized enterprises (SMEs).
A new report on Health Technology Assessment (HTA) processes published today...
EuropaBio welcomed yesterday’s landmark vote in the European Parliament in favour of the EU Cross-border Healthcare Directive.
Today EuropaBio hosts a high-level workshop on Health Technology Assessment (HTA) at the
International BIO Conference in Chicago.